Accepting New Patients
Phone: (813)-328-4120 Fax: (813)-328-4003 Email: emergencemat2021@gmail.com 5471 West Waters Avenue, Unit 300, Tampa, FL 33634
Emergence M.A.T.
OWCP Specialist
Covid-19 Clinic Policy

DEA has now allowed the use of Telemedicine for evaluating and initiating treatment for new patients for the duration of the current Health emergency.
DEA declaration dated March 31, 2020.

… despite the CSA’s limitations on issuing prescriptions for controlled substances by means of the Internet, for the duration of the public health emergency, a practitioner may prescribe a controlled substance to a new patient via telemedicine—using a real-time, two-way, interactive audio-visual communication—without first conducting an in-person examination. See 21 U.S.C. 802(54)(D).


At this time, we will not be renewing medications for the first visit. Patients must come into the clinic for the initial evaluation.




Requirements for enrollment through Telemedicine

• Reliable internet connection / wifi.

• Laptop / Computer / Cell Phone with camera.

• One and half to two hours of uninterrupted time.

• Credit / Debit Card and internet access to make payments.

• Ability to take a photograph or scan and send Driver License or approved ID.

• Ability to read and understand online consent forms and instructions.




Patients will have to come to the clinic for follow-up unless specifically directed to do so. This will be the policy till the public health emergency is lifted.


According to information posted on the DEA website at:

https://www.deadiversion.usdoj.gov/coronavirus.html

While a prescription for a controlled substance issued by means of the Internet (including telemedicine) must generally be predicated on an in-person medical evaluation (21 U.S.C. 829(e)), the Controlled Substances Act contains certain exceptions to this requirement.

One such exception occurs when the Secretary of Health and Human Services has declared a public health emergency under 42 U.S.C. 247d (section 319 of the Public Health Service Act), as set forth in 21 U.S.C. 802(54)(D).

Secretary Azar declared such a public health emergency with regard to COVID-19 on January 31, 2020 (https://www.hhs.gov/about/news/2020/01/31/secretary-azar-declares-public-health-emergency-us-2019-novel-coronavirus.html).

On March 16, 2020, the Secretary, with the concurrence of the Acting DEA Administrator, designated that the telemedicine allowance under section 802(54)(D) applies to all schedule II-V controlled substances in all areas of the United States.

Accordingly, as of March 16, 2020, and continuing for as long as the Secretary’s designation of a public health emergency remains in effect, DEA-registered practitioners in all areas of the United States may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met:

• The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional practice;

• The telemedicine communication is conducted using an audio-visual, real-time, two-way interactive communication system; and

• The practitioner is acting in accordance with applicable Federal and State laws.

Important note: If the prescribing practitioner has previously conducted an in-person medical evaluation of the patient, the practitioner may issue a prescription for a controlled substance after having communicated with the patient via telemedicine, or any other means, regardless of whether a public health emergency has been declared by the Secretary of Health and Human Services, so long as the prescription is issued for a legitimate medical purpose and the practitioner is acting in the usual course of his/her professional practice.

In addition, for the prescription to be valid, the practitioner must comply with applicable Federal and State laws.

https://www.deadiversion.usdoj.gov/coronavirus.html


This page was last updated on November 10, 2020
Mark A. Seldes, MD
Dr. Seldes is a board-certified family physician, He is experienced with OWCP medical reports and performing Impairment Rating examinations. Dr. Seldes and his qualified staff, assist in obtaining compensation and medical treatment after a work-related injury.
We perform both In-person examinations and Telehealth visits for our Florida residents who are already established patients. depending on the patient's needs.

Contact Us Today!
Phone: 813-328-4120, We are Open Monday-Friday, From 8:00 AM to 5:00 PM EST. (We are Currently Accepting New Patients)

Links
 

naabt.org
samhsa.gov
suboxone.com
zubsolv.com
bunavail.com
 
Suboxone Forums
suboxforum.com
AddictionSurvivors.org
smartrecovery.org
Clinic Policies
 

Fee Schedule
Resources
 

Self Help Resources
 
Medication Guides
Suboxone
Zubsolv
Bunavail
Buprenorphine
Naltrexone - Revia
Vivitrol Injection
Find Treatment
 

Physician Locator
Treatment Facility Locator
TreatmentMatch.org
 
Education/Information
Suboxone Cost
Methadone vs Suboxone

5/21/2024 3:59:23 AM